Bacteremia is a public health concern. Bacteremia-associated 30-day mortality remains .15% [1, 2] , and bacteremia is ranked as the tenth leading cause of death in the United States [3] . During the past several decades, there have been concerns about the increasing incidence of bacteremia in industrialized countries as the proportion of elderly people increases [4, 5] . At the same time, there has been an increase in the prevalence of several known risk factors for bacteremia, such as chemotherapy, immunosuppressive treatment, use of intravascular devices, and invasive medical procedures. These changes may affect the incidence and prognosis of bacteremia.
The estimated incidence of bacteremia in previous population-based studies has ranged from 125 episodes per 100,000 person-years in Finland [6] to 189 episodes per 100,000 person-years in Olmsted County, Minnesota [1] . The incidence appears to be increasing [6, 7] , whereas the associated 30-day mortality rates have remained constant or decreased slightly [7, 8] . Despite a number of population-based studies [1, 6, 7, [9] [10] [11] , little is known about the temporal changes in incidence and prognosis over extended time periods. In addition, few studies have distinguished between nosocomial, health-care associated, and communityacquired infections [10, 11] , and the distribution and temporal trends by place of acquisition remain unclear.
Temporal data on the occurrence and outcome of bacteremia may help us to better allocate health care resources and to evaluate the quality of health care. Therefore, we conducted this population-based cohort study to examine temporal changes in: (1) annual number of bacteremia episodes per 100,000 personyears; (2) annual bacteremia incidence, both overall and by place of acquisition; and (3) 30-day mortality, both overall and by place of acquisition.
MATERIALS AND METHODS

Setting and Study Population
We conducted this study in the North Denmark Region from 1992 through 2006. All Danish residents are provided free taxsupported medical care. Patients with bacteremia were treated in public hospitals (10 hospitals in 1992 and 7 hospitals in 2006), and Aalborg Hospital, an 800-bed university hospital, was both the region's referral hospital and the district hospital for the city of Aalborg [12] . All clinical specialties were represented in the region, with the exception of dermatology. However, patients who required solid-organ transplantation or allogenic bone marrow transplantation were transferred to national centers. We obtained data on the annual number of citizens in the region and, for the 1992-2005 period, also obtained information on the mean annual number of hospital admissions and hospital beddays from Statistics Denmark [13] (Table 1) .
Identification of Patients with Bacteremia
We defined bacteremia as a clinical entity associated with the presence of viable bacteria or fungi in the bloodstream evidenced by blood cultures in which contamination had been ruled out. Coagulase-negative staphylococci (CoNS), Corynebacterium species, Bacillus species, and Propionibacterium acnes were regarded as contaminants unless isolated from 2 or more separate blood culture sets [14] . Since 1981, the North Denmark Bacteremia Research Database has recorded all episodes of bacteremia in the region [12] , and since 1992, the episodes have been recorded at the time of the clinical events. Bacteremias were categorized by place of acquisition as nosocomial, communityacquired, or health care-associated. Nosocomial acquisition was defined according to the guidelines from the Centers for Disease Control and Prevention (CDC) [15] . Community-acquired bacteremia was defined as an infection that was present or incubating at hospital admission. Patients with a hospital stay in the 30 days prior to hospital admission or who had regular hospital visits (eg, for hemodialysis or chemotherapy) were categorized as having health care-associated bacteremia [16, 17] .
Characteristics of Bacteremia
We retrieved information on the annual number of patients with blood cultures from the laboratory information system (ADBakt; Autonik) (for the period 1995-2006). Three different blood culture systems were used: inoculation of blood into multiple tubes of bacteriological media (in 1992), the Colorbact system (Statens Serum Institut) [18] (during 1992-1995), and the BacT/ Alert system (bioMérieux) (during 1996-2006) [19] . We considered the empirical antibiotic treatment given at first notification of a positive blood culture to be appropriate only if administered intravenously (with the exception of fluoroquinolones and metronidazole, for which all routes of administration were regarded as appropriate) and only if the blood isolates were susceptible in vitro to 1 or more of the administered antibiotics. If the isolates were resistant or if the doses or the route of administration were insufficient, treatment was considered to be inappropriate [2, 12] .
Data on Comorbidity
Comorbidity was classified according to the Charlson Comorbidity Index [20] . We computed the index on the basis of all Overall bacteremia rate and incidence. As a measure of the disease burden in the population, we estimated the overall bacteremia rate as the total number of bacteremia episodes per 100,000 person-years. We calculated the annual rate by dividing the total annual number of bacteremia episodes by the number of citizens in the region at the beginning of that same year.
We classified patients as having incident bacteremia if they had a first-time diagnosis of bacteremia recorded from 1992 through 2006 and no bacteremia recorded from 1981 through 1991. To calculate annual incidence rates, we divided the number of patients with first-time bacteremia in a given year by the number of citizens in the region at the beginning of the year. When calculating the incidence of bacteremia according to place of acquisition, we regarded different places of acquisition as separate entities. That is, patients could have both a first-time community-acquired bacteremia and a first-time nosocomial bacteremia (for example). Because only hospitalized patients are at risk of nosocomial bacteremia, we also calculated the annual incidence of nosocomial bacteremia as the number of patients with first-time nosocomial bacteremia divided by the number of hospital bed-days in that same year.
To compare the rates in different years, we standardized the rates to the age and sex distribution of the population of the North Denmark Region in 1992 using direct standardization.
Mortality. For patients with a first-time bacteremia episode, we constructed Kaplan-Meier mortality curves and computed the cumulative mortality by study period. We used logistic regression analysis to estimate the crude and adjusted risk of death in the 30 days after the date of the first positive blood culture by year of diagnosis. We adjusted for place of acquisition, age, sex, level of comorbidity, marital status, focus of infection (urinary, respiratory, abdominal, miscellaneous, or unknown), and appropriateness of empirical treatment. To further assess the temporal changes, we stratified according to place of acquisition and computed the age-standardized 30-day mortality using a 3-year moving average to smooth the underlying variation.
Statistical analyses were performed with Stata Statistical Software, version 9.2 (Stata). The study was approved by the Danish Data Protection Agency (record no. 2006-41-7413).
RESULTS
Descriptive epidemiology. During the study period, the mean annual number of hospital admissions increased by 4%, from 93,548 during 1992-1997 to 97,293 during 2002-2006. In contrast, the mean annual number of hospital bed-days decreased 9%, from 525,770 to 479,938 (Table 1 ). Mean annual number of patients who had blood cultures performed increased by 46%, from 5999 to 8776, but the proportion of patients with bacteremia remained unchanged.
There were 14,303 episodes of bacteremia from 1992 through 2006, of which 11,703 (81.8%) were incident (ie, first-time) episodes. A total of 12,535 patients had a first-time diagnosis of community-acquired bacteremia (5941 patients; 47.4%), nosocomial bacteremia (4619 patients; 36.9%), or health care-associated bacteremia (1975 patients; 15.8%). Table 2 (Table 1 and Figure 1 ).
Overall bacteremia rate and incidence. The age-and sexstandardized rate of bacteremia increased overall, from 120 bacteremia episodes per 100,000 person-years in 1992 to 201 bacteremia episodes per 100,000 person-years in 2006 ( Figure  1A ). The age-and sex-standardized overall incidence increased from 114 to 166 episodes per 100,000 person-years from 1992 through 2006, corresponding to an age-and sex-standardized incidence rate ratio of 1.46 (95% CI, 1.36-1.59). Highest incidence rates were observed for community-acquired bacteremia, and the age-and sex-standardized incidence rates of community-acquired and nosocomial bacteremia peaked at 92.1 and 77.2 episodes per 100,000 person-years in 2004 and 2002, respectively ( Figure 1B) . The incidence of nosocomial bacteremia per 100,000 hospital bed-days paralleled the incidence per 100,000 person-years, showing an increase from 45.4 episodes per 100,000 hospital bed-days in 1992, to a peak of 77.7 episodes per 100,000 hospital bed-days in 2002, followed by a decrease to 65.2 episodes per 100,000 hospital bed-days in 2005. For health care-associated bacteremia, the incidence per 100,000 personyears increased almost 14-fold (from 2.9 episodes in 1992 to 39.8 episodes in 2006).
Mortality. The absolute number of patients with first-time bacteremia who died within 30 days after a bacteremia diagnosis increased by 24.8%, from 742 during 1992-1996 to 926 during [2002] [2003] [2004] [2005] [2006] (Table 3 ). The 30-day mortality was 22.7% b Central nervous system, muscles, skin, joints and bones, genital system, and intravascular devices.
c The treatment was completed or the patients had either died or were in the terminal stages of disease. 
DISCUSSION
This population-based study found that the overall annual rate of bacteremia increased by 68% and that the incidence increased by 47% from 1992 through 2006, with the largest increase observed for health care-associated bacteremia. Concomitantly, the annual number of patients with blood cultures performed almost doubled. There was a slight decrease in 30-day mortality associated with community-acquired bacteremia, but the total number of patients who died within 30 days after a first episode of bacteremia increased. The overall annual incidence of bacteremia found in this study, 114-166 episodes per 100,000 person-years, was comparable to estimates from the few other contemporary population-based studies conducted in Olmsted County (in the United States) [1] , Finland [6] , and North Denmark [7] . A few earlier studies also reported considerable increases in the bacteremia incidence rates. Specifically, a previous study in North Denmark reported a 100% increase in the incidence of bacteremia from 1981 through 1994 (from 76 to 153 episodes per 100,000 person-years) [7] , and in Finland, the incidence increased by 40% from 1995 through 2002 (from 104 to 145 episodes per 100,000 person-years) [6] . However, none of these studies related these changes to the place of acquisition. The mean age-and sex-standardized incidence rate of communityacquired bacteremia in the present study, 92.7 episodes per 100,000 population, was slightly higher than the rate reported by Laupland et al. [11] (81.7 episodes per 100,000 population) in Calgary, Canada, during 2000-2004. These differences may be attributable in part to differences in definitions. The Canadian study defined community-acquired bacteremia as bacteremias diagnosed in the 48 h after hospital admission. We did not rely entirely on a predefined time-period; instead, we assessed each individual case and based the classification on all of the clinical and microbiological information obtained during hospitalization [12, 22] .
During the study period, Escherichia coli was the most common pathogen, regardless of place of acquisition, followed by Staphylococcus aureus and Streptococcus pneumoniae. This rank order is similar to that found in recent studies conducted in England and Wales [23] , in Olmsted County [1] , and in Canada [11] . Thus, we found no shift toward gram-positive bacteria, as reported previously [8, 24] . Urinary tract and gastrointestinal foci accounted for approximately one-half of the episodes, and the prevalence of bacteremias with urinary tract foci increased by 20%. This was reflected in an increasing proportion of E. coli bacteremias, which are often secondary to focal infections within the urinary and gastrointestinal tracts [25, 26] .
There are several other plausible explanations for the increasing incidence. The number of residents and hospital admissions changed minimally during the study. Because we standardized the rates, demographic changes in the study population cannot explain the observed changes. Nonetheless, possible risk factors for bacteremia, such as comorbidity [21, 27] , have become more prevalent in Denmark because of population aging, changing lifestyle factors, and longer disease survival [28] . Another explanation is a potential increase in the identification of bacteremia. Notably, the blood culture systems and media improved during the study period, and as shown previously in Finland [6] , we observed a sustained increase in the annual number of patients with blood cultures performed. Thus, physicians may have lowered the threshold for ordering blood cultures. Still, the proportion of patients with bacteremia remained virtually unchanged. Finally, the decrease in the mean annual number of bed-days indicates a decrease in the mean length of inpatient stays. More patients may have received outpatient treatment, which could explain the large increase in health care-associated bacteremia.
The 30-day mortality rates improved slightly during the 15-year study period, but because of the increasing incidence, the total number of deaths increased substantially. We are aware of 2 other population-based studies that evaluated temporal trends in mortality after bacteremia [7, 8] . Our findings are similar to the findings in a sepsis study that was based on hospital discharge records in the United States during 1979-2000 [8] . In that study, crude in-hospital mortality decrease from 27.8% during 1979-1984 to 17.9% during 1995-2000. However, the mortality estimates may have been influenced by changes in coding practice and by the use of in-hospital mortality as outcome (the mean length of hospital stay [6 standard deviation] decreased from 17.0 6 8.5 days to 11.8 6 2.6 days during the same time periods) [8] . In contrast, the study from North Denmark [7] reported relatively constant 30-day mortality from 1981 through 1994. Neither of these studies related mortality from bacteremia to the place of acquisition. Changes in prognosis may be attributable to changes in diagnosis and to better treatment. Improved diagnosis and increased ascertainment may have resulted in identification of milder cases of bacteremia with better prognosis. The increased proportion of gram-negative isolates (of E. coli, in particular) may explain some of the reduction in mortality associated with community-acquired bacteremia. As indicated above, these isolates often stem from localized urinary and gastrointestinal tract infections that inherently have a more-favorable prognosis. Early and appropriate antibiotic administration remains the mainstay in bacteremia treatment [29] , and we observed a 7% reduction in the proportion of patients who received inappropriate empirical antibiotic treatment. The prevalence of acquired antibiotic resistance remained low and fairly constant during the first half of our study period [30] [31] [32] , and although national surveillance data indicated an increasing trend in the most recent period, methicillin-resistant S. aureus (MRSA), vancomycin-resistant enterococci, and penicillin-resistant pneumococci remain a marginal problem [33, 34] . Therefore, we find it unlikely that changing levels of antibiotic resistance influenced our estimates of all-cause 30-day mortality. Other factors that may explain the decreasing mortality include improved hospital management of patients with bacteremia [35] .
Because universal health care coverage in Denmark allowed a population-based study, we were able to include all episodes of hospitalized bacteremia during a 15-year period, with complete follow-up for mortality. One potential limitation to the study is that blood cultures may not have been performed for all patients with a likelihood of bacteremia. The decision to obtain blood cultures is based on clinical judgment, so we may have missed some episodes if blood cultures were not taken. This would result in an underestimation of the true incidence of bacteremia. If physicians lowered their threshold for obtaining blood cultures during the study period, we probably missed fewer bacteremias in the latter part of the study. Furthermore, patients who received antimicrobial treatment prior to providing samples for culturing may have had false-negative culture results. Our estimates of incidence and mortality by place of acquisition are dependent on our definitions. In agreement with SiegmanIgra et al. [17] , we used a 30-day period for identifying prior hospitalization. Others have used periods ranging from 90 days to .1 year [36] [37] [38] . Moreover, we lacked information on nursing home residence. However, the policy in Denmark is to provide extensive home-based support even to frail elderly individuals, and the number of nursing homes has decreased markedly during the previous 20 years. Another concern is coding errors in the routine hospital data used to identify comorbidities. Misclassification of comorbidities may have led to residual confounding that could affect our relative mortality estimates.
In conclusion, the incidence of bacteremia in Northern Denmark has increased considerably over the past 15 years. Although mortality associated with bacteremia decreased, the total number of patients who died in the 30 days after experiencing a first episode of bacteremia increased. These results emphasize the public health importance of bacteremia and highlight the need for preventive measures and improved care to reduce the incidence rates and to further improve prognosis.
